Scholar : Acta Oncologica, Volume 56, Issue 9, September 2017 is now available online on Taylor & Francis Online

@media screen and (max-width:400px) { .two .column, .two .left, .two .right{ max-width: 100% !important; } } @media screen and (min-width: 401px) and (max-width:620px){ .two .column, .two .left, .two .right { max-width: 100% !important; } }

The online platform for Taylor & Francis Online content Acta Oncologica, Volume 56, Issue 9, September 2017 is now available online on Taylor & Francis Online. This new issue contains the following articles: EDITORIAL What conclusions can be drawn from the Stockholm III rectal cancer trial in the era of watch and wait? B. Glimelius & A. Martling Pages: 1139-1142 | DOI: 10.1080/0284186X.2017.1344359 REVIEW Dose intense, dose dense and tailored dose adjuvant chemotherapy for early breast cancer: an evolution of concepts Alexios Matikas, Theodoros Foukakis & Jonas Bergh Pages: 1143-1151 | DOI: 10.1080/0284186X.2017.1329593 LETTER TO THE EDITOR The feasibility of short-course radiotherapy in a watch-and-wait policy for rectal cancer K. Bujko, L. Pietrzak, M. Partycki, M. Szczepkowski, L. Wyrwicz, M. Rupiński, A. Rutkowski & A. Mróz Pages: 1152-1154 | DOI: 10.1080/0284186X.2017.1327721 ORIGINAL ARTICLES: BREAST CANCER Validity of Danish Breast Cancer Group (DBCG) registry data used in the predictors of breast cancer recurrence (ProBeCaRe) premenopausal breast cancer cohort study Deirdre P. Cronin-Fenton, Anders Kjærsgaard, Thomas P. Ahern, Marco Mele, Marianne Ewertz, Stephen Hamilton-Dutoit, Peer M. Christiansen, Bent Ejlertsen, Henrik T. Sørensen, Timothy L. Lash & Rebecca A. Silliman Pages: 1155-1160 | DOI: 10.1080/0284186X.2017.1327720 A high level of estrogen-stimulated proteins selects breast cancer patients treated with adjuvant endocrine therapy with good prognosis Katrine L. H. Weischenfeldt, Tove Kirkegaard, Birgitte B. Rasmussen, Anita Giobbie-Hurder, Maj-Britt Jensen, Bent Ejlertsen & Anne E. Lykkesfeldt Pages: 1161-1167 | DOI: 10.1080/0284186X.2017.1324211 The will to live – breast cancer patients perceptions' of palliative chemotherapy Jenny Bergqvist & Peter Strang Pages: 1168-1174 | DOI: 10.1080/0284186X.2017.1327719 ORIGINAL ARTICLES: LUNG CANCER Miliary metastases are associated with epidermal growth factor receptor mutations in non-small cell lung cancer: a population-based study Fred Hsu, Alan Nichol , Ted Toriumi & Alex De Caluwe Pages: 1175-1180 | DOI: 10.1080/0284186X.2017.1328128 Correlation analysis of [18F]fluorodeoxyglucose and [18F]fluoroazomycin arabinoside uptake distributions in lung tumours during radiation therapy Dario Di Perri , John A. Lee, Anne Bol, François-Xavier Hanin, Guillaume Janssens, Daniel Labar, Annie Robert, Edmond Sterpin & Xavier Geets Pages: 1181-1188 | DOI: 10.1080/0284186X.2017.1329594 Accuracy of the dose-shift approximation in estimating the delivered dose in SBRT of lung tumors considering setup errors and breathing motions Kristin Karlsson, Ingmar Lax, Elias Lindbäck & Gavin Poludniowski Pages: 1189-1196 | DOI: 10.1080/0284186X.2017.1310395 ORIGINAL ARTICLES: HEAD-AND-NECK CANCER Parotid gland mean dose as a xerostomia predictor in low-dose domains Hubert Szymon Gabryś , Florian Buettner , Florian Sterzing, Henrik Hauswald & Mark Bangert Pages: 1197-1203 | DOI: 10.1080/0284186X.2017.1324209 Increasing incidence and survival in oral cancer: a nationwide Danish study from 1980 to 2014 Kirstine Kim Schmidt Karnov , Christian Grønhøj, David Hebbelstrup Jensen, Irene Wessel, Birgitte Wittenborg Charabi, Lena Specht, Andreas Kjaer & Christian von Buchwald Pages: 1204-1209 | DOI: 10.1080/0284186X.2017.1307516 ORIGINAL ARTICLES: SUPPORTIVE CARE Admittance to specialized palliative care (SPC) of patients with an assessed need: a study from the Danish palliative care database (DPD) Mathilde Adsersen, Lau Caspar Thygesen, Mette Asbjoern Neergaard, Anders Bonde Jensen, Per Sjøgren, Anette Damkier & Mogens Groenvold Pages: 1210-1217 | DOI: 10.1080/0284186X.2017.1332425 Adverse events in hospitalised cancer patients: a comparison to a general hospital population | Ellinor Christin Haukland, Christian von Plessen, Carsten Nieder & Barthold Vonen Pages: 1218-1223 | DOI: 10.1080/0284186X.2017.1309063 ORIGINAL ARTICLES: GASTROINTESTINAL CANCER Significance of baseline FDG-PET/CT scan as a method of staging regional lymph nodes in patients with operable distal oesophageal or gastroesophageal junction adenocarcinoma George Papaxoinis, Jamie M. J. Weaver, Leila Khoja, Ana Patrao, Sofia Stamatopoulou, Alia Alchawaf, Vikki Owen-Holt, Theodora Germetaki, Zoe Kordatou & Wasat Mansoor Pages: 1224-1232 | DOI: 10.1080/0284186X.2017.1328127 LETTERS TO THE EDITOR Fatal heart failure in a young adult female sarcoma patient treated with pazopanib | Vicky L. M. N. Soomers, Ingrid M. E. Desar, Nielka P. van Erp, Jeroen Verwiel, Suzanne E. J. Kaal & Winette T. A. van der Graaf Pages: 1233-1234 | DOI: 10.1080/0284186X.2017.1296582 Combined modality therapy improves overall survival for angiosarcoma Colette J. Shen, Aaron S. Parzuchowski, Megan N. Kummerlowe, Carol D. Morris, Christian F. Meyer, Mehran Habibi, Deborah A. Frassica, Adam S. Levin, Katherine A. Thornton & Stephanie A. Terezakis Pages: 1235-1238 | DOI: 10.1080/0284186X.2017.1306104 Boosting axitinib exposure with a CYP3A4 inhibitor, making axitinib treatment personal Floor J. E. Lubberman, Nielka P. van Erp, Rob ter Heine & Carla M. L. van Herpen Pages: 1238-1240 | DOI: 10.1080/0284186X.2017.1311024 Radiation physiology – evidence for a higher biological effect of 24 Gy in four fractions as compared to three Gunnar Steineck , Cecilia Bull, Marie Kalm, Fei Sjöberg, Eleftheria Alevronta, Dilip Kumar Malipatlolla, Karin Bergmark, Bengt Jeppsson, Ulrica Wilderäng & Thomas Björk-Eriksson Pages: 1240-1243 | DOI: 10.1080/0284186X.2017.1309062 Mid-treatment magnetic resonance imaging in pediatric intracranial low-grade gliomas treated with proton beam therapy Radhika Sreeraman Kumar, Ronny L. Rotondo, Julie A. Bradley, Tamara Vern-Gross, Soon Huh & Daniel J. Indelicato Pages: 1243-1247 | DOI: 10.1080/0284186X.2017.1306105 To update which email alerts you receive, manage your alerts within the My Account area. You can also unsubscribe from this alert with one click. If you need any further help, please contact us at support@tandfonline.com Please do not reply to this email. To ensure that you receive your alerts and information from Taylor & Francis Online, please add "alerts@tandfonline.com" and "info@tandfonline.com" to your safe senders list. Taylor & Francis, an Informa business. Taylor & Francis is a trading name of Informa UK Limited, registered in England under no. 1072954. Registered office: 5 Howick Place, London, SW1P 1WG.